GB2151943A - Plasmapheresis apparatus - Google Patents

Plasmapheresis apparatus Download PDF

Info

Publication number
GB2151943A
GB2151943A GB08504768A GB8504768A GB2151943A GB 2151943 A GB2151943 A GB 2151943A GB 08504768 A GB08504768 A GB 08504768A GB 8504768 A GB8504768 A GB 8504768A GB 2151943 A GB2151943 A GB 2151943A
Authority
GB
United Kingdom
Prior art keywords
channel
particle mixture
filtrate
channels
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB08504768A
Other versions
GB2151943B (en
GB8504768D0 (en
Inventor
Glen Delbert Antwiler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo BCT Inc
Original Assignee
Cobe Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cobe Laboratories Inc filed Critical Cobe Laboratories Inc
Publication of GB8504768D0 publication Critical patent/GB8504768D0/en
Publication of GB2151943A publication Critical patent/GB2151943A/en
Application granted granted Critical
Publication of GB2151943B publication Critical patent/GB2151943B/en
Expired legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D65/00Accessories or auxiliary operations, in general, for separation processes or apparatus using semi-permeable membranes
    • B01D65/08Prevention of membrane fouling or of concentration polarisation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D25/00Filters formed by clamping together several filtering elements or parts of such elements
    • B01D25/12Filter presses, i.e. of the plate or plate and frame type
    • B01D25/172Plate spreading means
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D25/00Filters formed by clamping together several filtering elements or parts of such elements
    • B01D25/12Filter presses, i.e. of the plate or plate and frame type
    • B01D25/21Plate and frame presses
    • B01D25/215Construction of the filter plates, frames
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/147Microfiltration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/22Controlling or regulating
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D63/00Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/08Flat membrane modules
    • B01D63/082Flat membrane modules comprising a stack of flat membranes
    • B01D63/0822Plate-and-frame devices
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2321/00Details relating to membrane cleaning, regeneration, sterilization or to the prevention of fouling
    • B01D2321/20By influencing the flow
    • B01D2321/2008By influencing the flow statically

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Filtration Of Liquid (AREA)

Abstract

A device 20 for separating a liquid filtrate free of particles larger than a predetermined size from a liquid mixture of said particles such as blood, said device 20 comprising a housing means including a port plate 104 having a particle mixture inlet port 22, a particle mixture outlet port 26, and a filtrate outlet port 28, and an end plate 106, and a microporous membrane 112 mounted between said plates to define a particle mixture flow channel B and filtrate channel P with said housing means, said channel B being in communication with said port 22 and said port 26, said channel P being in communication with said port 28. A plurality of membranes 112 separated by support plates 110 may be used. The peripheries of said plates 104, 106, 110 are welded together. <IMAGE>

Description

1 GB 2 151 943 A 1
SPECIFICATION
A device for separating filtrates free of particles from liquid particle mixtures The invention relates to a device for separating liquid filtrates free of particles larger than a predetermined 5 size from liquid mixtures of the particles.
According to the invention there is provided a device for separating a liquid filtrate free of particles larger than a predetermined size from a liquid mixture of said particles, said device comprising a housing means including a port plate having a particle mixture inlet port, a particle mixture outlet port, and a filtrate outlet port, and an end plate, and a microporous membrane mounted between said plates to define a particle mixture flow channel and filtrate channel with said housing means, said particle mixture flow channel being in communication with said particle mixture inlet port and said particle mixture outlet port, said filtrate channel being in communication with said filtrate outlet port, the peripheries of said plates being welded together.
The device may comprise a microporous membrane with pores of said predetermined size mounted 15 within said housing means to define a particle mixture flow channel and a filtrate channel, each said channel being bounded on one side by opposite sides of said membrane, and means to actively vary the geometry of said particle mixture flow channel or said filtrate flow channel during operation of said apparatus.
The housing means may have a particle mixture inlet manifold, a particle mixture outlet manifold, and a filtrate outlet manifold, and said particle mixture inlet and outlet manifolds may be sufficiently large to cause 20 pressure drops sufficiently smallerthan the pressure drop along said particle mixture flow channel to permit measurements of the change in pressure along said particle mixture flow channel based upon measurements of pressure in external lines connecting to said particle mixture manifolds, said housing means and said microporous membrane being adapted to cause variation in the geometry of said particle mixture flow channel of said filtrate channel in response to the application of an external force to said housing means.
Said housing means may include an elastic shim in sealable contact with said microporous mernbrane to cause a decrease in the height of one of said channels when said shim is compressed.
It has been discovered that providing a microporous membrane filtration device with means to actively vary the geometry of either the particle mixture flow channel or the filtrate channel during operation provides increased versatility in varying different control parameters in the device in response to the existing or desired operating conditions such as inlet flowrate, inlet particle concentration, and filtration rate, which operating conditions may vary with time or from one application to another. For example, a desired flowrate for supplying the particle mixture to the device can be maintained, and the shear rate and other control parameters can be varied to optimize the flux but avoid clogging and particle cell wall rupture simply by 35 adjusting the height of the channel.
In preferred embodiments, the height of the particle mixture flow channel facing the membrane is varied by compressing the membrane separating device; the membrane separating device is compressed in a fixture between a front plate and a piston plate that is slidably mounted along an axis transverse to the front plate, and pressure is applied to the rear of the piston plate to varythe compression applied to the separating 40 device; the front plate of the fixture has holes in it through which the ports forthe membrane filtration device pass; the fixture includes a back plate behind the piston plate, and the back plate is sealably connected to the piston plate by a diaphragm to define a pressure chamber between the back plate and the piston plate, and the back plate is fixably mounted with respect to the front plate so that increases in pressure in the pressure chamber result in compressing the filtration device between the piston plate and the front plate; the 45 geometry of the flow channel is varied in response to changes in a control parameter of the separating device; the control parameter is the pressure drop in the particle mixture channel from the inlet to the outlet; means are included to detect the pressure drop in the particle mixture channel-from the inlet to the outlet, to detect the flowrate of the particle mixture into the separating device, and to maintain a proportional relationship between the pressure drop and the particle mixture flowrate by varying the height of the particle 50 mixture channel; the proportional relationship between pressure drop and the particle mixture flowrate is maintained so long as the pressure drop is below a predetermined level, and the pressure drop is maintained at the predetermined level for increases in the particle mixture flowrate above that corresponding to the predetermined pressure drop level; the transmembrane pressure is maintained at a predetermined level by adjusting the rate of flow of the filtrate; the particle mixture inlet port is connected to an access line for a patient, and the concentrated particle mixture leaving the device is returned to the patient with a replacement fluid; the particles are formed elements; and the filtrate is plasma.
Another embodiment of the invention features a separating device having a membrane mounted within housing means to define a particle mixture channel and a filtrate channel. The means defining the filtrate channel provides a flow restriction in the filtrate channel so that there is a pressure drop along the filtrate flow path caused by the filtrate flow. This passively acts to reduce the changes in transmembrane pressure along the membrane, permitting the use of larger velocity gradients in the particle mixture flow channel and thus higher flux along the membrane. In some preferred embodiments the flow restriction means includes means with V-shaped grooves facing the membrane to provide V-shaped channels having depths that are shallower at upstream portions than downstream portions; in other preferred embodiments the flow 65 2 GB 2 151 943 A 2 restriction means includes means providing a surface with a roughness along the filtrate channel large enough to permit flow between the surface and the membrane, but small enough to provide the desired pressure drop; in other preferred embodiments the flow restriction means is a flow obstructor placed in the filtrate channel (e.g., cloth orfibrous material); there are pluralities of membranes, means to define filter channels, particle mixture flow channels, and filtrate channels, and the plurality of means to define filtrate channels are parallel plates; the housing means and microporous membranes are adapted to cause variation in the geometry of particle mixture flow channels in response to the application of an external force to the housing; the variation in geometry is variation in height; and the housing means includesa shim in sealable contact with the microporous membrane.
Another embodiment of the invention also features a separating device having a membrane mounted within housing means to define a particle mixture channel and a filtrate channel. When external force is applied to the housing means, variation of the geometry of the particle mixture channel results. Also, the housing means and membrane provide particle mixture inlet and outlet manifolds that are sufficiently large to have pressure drops associated with them that are small enough to permit determining the drop in pressure in the particle mixture flow channel by taking measurements in external lines connected to the ports. In preferred embodiments there are pluralities of membranes, means to define filtrate channels, filtrate channels and particle mixture flow channels, and the plurality of means to define filtrate channels are parallel plates; the housing means includes a shim in sealable contact with the microporous membrane; and the variation in geometry is variation in height.
In one embodiment, the device is adapted to cause variation in the geometry of its particle mixture 20 channels or its filtrate channels in response to the application of external force to the device. In preferred embodiments there are pluralities of plastic membrane support plates between the port plate and the end plate and pluralities of particle mixture channels, filtrate channels and membranes, and the peripheries of the plates are welded together; there are two membranes between each pair of membrane support plates; there is a shim to provide a seal with at least one membrane; and the device is adapted to cause variation in 25 the height ofthe particle mixture channels in response to application of an external force to the port plate and the end plate.
Another embodiment ofthe invention also features a separating device having a membrane mounted within housing means to define a particle mixture channel and a filtrate channel. The housing means includes an elastic shim in sealable contact with the membrane to cause a decrease in the height of one of 30 the channels when the shim is compressed. In preferred embodiments there are pluralities of membranes, filtrate channels, and particle mixture channels, and the housing means includes a plurality of parallel plates; and the particle mixture channel is defined by a pair of membranes separated by the elastic shim.
Another embodiment of the invention features a separating device having a pair of microporous membranes mounted within housing means to define a particle mixture flow channel between the membrane and a pair offiltrate channels, each filtrate channel being bounded on one side by a membrane.
By using two membranes to define the particle mixture channel, both largearea surfaces ofthe particle mixture flow channel are active in separating the filtrate. In a preferred embodiment, there are pluralities of membranes, filtrate channels, and particle mixture channels, and the housing means includes a plurality of parallel plates.
The structure and operation of one presently preferred embodiment ofthe invention will now be described by way of example, and with reference to the drawings, in which:
Figure 1 is a schematic representation of blood cell separation apparatus according to the invention; Figure 2 is a perspective view of a separating device and a fixture of the Figure 1 apparatus; Figure 3 is a vertical sectional view, taken at 3-3 of Figure 2, of the Figure 2 fixture; Figure 4 is a horizontal sectional view, taken at 4-4 of Figure 3, of said fixture; Figure 5 is an exploded perspective view of said separating device; Figure 6 is an exploded perspective view of one set of channels of said separatory device; Figure 7 is a diagrammatic vertical sectional view of a portion of the Figure 6 set of elements; Figure 8 is a diagrammatic vertical sectional view of a portion of the Figure 6 set of elements when compression has been applied to the separating device; Figure 9 is a block diagram of control electronics for the Figure 1 system; and Figure 10 is a vertical sectional view, taken at 10-10 of Figure 6, of an alternative embodiment of a plate element ofthe Figure 5 separating device.
The construction of the embodiment will be described first, then its operation.
Referring to Figure 1, there is shown plasmapheresis apparatus 10 for separating plasma (small blood components including immunoglobulins, albumin and other proteins) from the "formed elements" (red blood cells, white blood cells and platelets) in a patient's blood and returning the formed elements to the patient with a makeup fluid. This process has utility in various applications, including therapeutically removing pathogenic substances contained in the plasma portion of a patient's blood. Apparatus 10 includes 60 blood inflow line 12 and blood return line 14, for connection to lines attached to the patient. Line 12 has pressure sensor 15 and associated drip chamber 17 upstream of peristaltic blood pump 16 to monitor the blood pressure in the access line 12. Also referring to Figure 3, it is seen that piston plate 58 has circular piston projections 62,64 extending from its rear surface. Rolling diaphragms 66, 68 are connected to the 3 GB 2 151 943 A 3 faces of piston projections 62, 64 by screws 70, 72 and circular retainers 74,76, respectively. The peripheries of diaphragms 66, 68 are sealably sandwiched between bonnets 78, 80 and the inner surface of back plate 82.
Back plate 82 has cylindrical depressions 84, 86 for receiving the two piston projections and their associated retainers. Female swivel connection 88, for connection to pressure source 40, communicates with depression 86, and air bleeding valve 41 communicates with depression 84. Channel 90 provides communication between depression 84,86.
Referring to Figure 4, it is seen thatfront plate 54 has a pair of Vshaped grooves 92 for mating with V-shaped projections 94 extending rearwardly from transverse extensions of side supports 56, 57. Pins 96 extend inwardly from side supports 56, 57, and their unsupported ends are within vertical grooves 98, which run along the sides of front plate 54. Portions of bonnet 78, the periphery of diaphragm 66, and the associated periphery of back plate 82 are shown within recesses 100, 102 in side supports 56, 57.
Referring to Figure 5, there is shown an exploded view of separating device 20. Blood inlet port 22, blood outlet port 26, and plasma outlet port 28 are formed on the front of plastics port plate 104. Between port plate 104 and end plate 106 are six sets 108 of plasma-blood-plasma channels (only three sets are shown in Figure 5), each set 108 including two membrane support plates 110, two plastics, microporous membranes 112 (approximately 0.17 mm thick, and having an average pore size of 0.6 micron) and 1.02 x 10-4M (0.004 inch) thick polyethylene shim 114 between membranes 112. Adjacent plasma-blood- plasma channel sets 108 share a common membrane support plate 110. Referring to Figure 6, the plates, membranes, and shim for one set 108 of the channels are shown. Blood channels B are provided between membranes 112, and plasma channels P are provided between membrane support plates 110 and membranes 112. Each membrane plate 20 is made of acrylonitrile butacliene styrene (ABS), and is approximately 2. 90 X 10-3m (0.114 inch) thick, 0.22m (8 3/4 inches) long, and 0.083m (3 1/4 inches) wide. Holes 116 in plates 110 and holes 130 in membranes 112 are aligned with inlet port 22 to provide for the flow of incoming blood from inlet port 22 to all of blood channels B in channel sets 108. Holes 118 in plates 110 are similarly aligned with blood outlet port 26 and holes 132 in membranes 112 to provide for flow of the concentrated formed element mixture from blood channels B to outlet port 26. Holes 120 in plates 110 are aligned with plasma outlet port 28 and holes 134 in membranes 112 to provide forflow of plasma from plasma filtrate channels P to plasma outlet port 28.
On both the upper and lower surfaces of plates 110 are a plurality of elongated V-shaped grooves 112, which are separated by three parallel ribs 124. Around the perimeters of upper and lower surfaces 123 of plates 110, encompassing holes 116,118,120 and grooves 122, are continuous sealing beads 126, which each has a hemispherical cross-section of approximately 1.3 x 10-4M (0. 005 inch) radius and extends above or belowthe planes of surfaces 123 of plate 110. As can be seen from Figures 7 and 8, beads 126 on the upper and lower surfaces are not aligned with each other. Similar continuous sealing beads 133 surround holes 120 on plate 110. V-shaped grooves 122 are formed by surfaces making 45' angles with surface 123 and are approximately 1.02 x 10-3M (0.04 inch) wide and 5.08 x 104M (0.02 inch) deep. Tips 125 of plate portions between adjacent grooves 122 (Figures 7 and 8) are approximately 7.6 x 1 0-5m (0.003 inch) above or below surfaces 123. The upper surfaces of ribs 124 are at the same level as surface 123. Grooves 122 end near plasma outlet port 120 at transverse plasma outlet channel 128, which collects plasma from the grooves and directs it to elbow channel 129, which passes under sealing beads 133 and communicates with the interior of 40 plasma outlet hole 120 between outer surfaces 123. On the longitudinal ends of plate 110 are holes 180 and protuberances 182 for mating with corresponding protuberances and holes on adjacent plates to provide alignment during assembly.
When assembled, portions of membranes 112 surrounding holes 130 and 132 are heat-sealed to facing portions of plates 110 to provide inlet and outlet blood manifold seals and prevent leakage betwe6n the blood and plasma channels. Plates 110, membranes 112, and shims 114 are brought together. Sealing beads 126 provide a good seal between shims 114, membranes 112 and plates 110. The peripheries of the plates are welded together so that melted ABS from adjacent plates 110 mix together. As can be seen in Figures 7 and 8, the edges of membranes 112 and shims 114 are inside the edges of plates 110. Atthe ends of the stack, melted plastics material from port plate 104 and end plate 106 and the adjacent support plates 110 similarly mixes together, thus connecting and sealing the entire stack together to form device 20. Portions of membranes 112 surrounding holes 134 are squeezed by continuous sealing beads 133 formed on the surfaces of plates 110 around holes 120 to provide plasma outlet channels isolated from blood outlet holes 118. Although holes 135, transverse channels 139, elbow channels 137, and sealing beads 141 (which are similar to holes 120, transverse channels 128, elbow channels 129, and sealing beads 133) are provided on 55 the inlet side of plate 110 for ease of manufacture and assembly, there is no hole in port plate 104 corresponding to plasma port 128; thus, plasma collected in V-grooves 122 is directed to holes 120 communicating with plasma outlet port 28.
Port plate 104, end plate 106, membrane support plates 110 and shim 114 all act together as housing means to define the plasma and blood channels with microporous membrane 112.
A blood inlet manifold distributing blood from inlet port 22 to channels B is provided by holes 116, membranes 112, holes 130, and the semicircular and triangular depressions formed in the surfaces of plates around holes 116. A blood outlet manifold is similarly provided by holes 118, membranes 112, holes 132 and the semicircular and triangular depressions formed in the surfaces of plates 110 around holes 118. Both of these manifolds are sufficiently large to cause pressure drops sufficiently smaller than the pressure drop 65 4 GB 2 151 943 A 4 along blood flow channels B to permit determination of the change in pressure along the blood flow channels based upon measurements of pressure in external lines connected to the blood inlet and outlet ports.
The operation of the embodimentwill now be described.
In operation, blood access line 12 and return line 14 are connected to the patient. Incoming blood travels through line 12, pump 16, and line 24 to inlet port 22 of separating device 20. Blood flows through holes 116 of plates 110 and holes 130 of membranes 112 and enters blood channels B between membranes 112.
Because of the seals of portions of membranes 112 surrounding membrane holes 130 to facing portions of plates 110 surrounding holes 116, there is no flow of incoming blood to the plasma sides of membranes 112 facing plates 110, unless it passes through membranes 112.
Normally the pressure in blood channels B is higher than the pressure in plasma channels P on the other sides of membranes 112, and this causes membranes 112 to be forced against tips 125 of plates 110, thereby forming blood channels B. Components of the blood that are smallerthan the pores of membranes 112 pass through membranes 112 and flow down the channels formed by V-grooves 122 and the facing surfaces of membranes 112 to transverse outlet channel 128, elbow channel 129, and plasma outlet holes 120 in plate 110. Because of the pressure seal between sealing beads 133 and portions of membrane 112 surrounding holes 134, there is no leakage between plasma channels P and blood channels B. The formed elements, which are larger than the pores of membrane 112, and other components which did not pass through membranes 112, flow to blood outlet holes 132 in membranes 112 and holes 118 in plates 110. Once again, the heat seals between portions of membranes 112 surrounding holes 132 and portions of 20 plate 110 surrounding holes 118 prevent the leakage of formed elements into the plasma channels P. There is a gradual depression in plates 110 in portions surrounding holes 116,118, and the blood pressure forces corresponding portions of membrane 112 against plates 110. Channels 128 are thin enough, and membranes 112 are rigid enough, to prevent blockage of channels 128 by membranes 112 at the pressures used.
Referring to Figure 1, the plasma filtrate from port 28 flows through line 30, drip chamber 32, and pump 34 25 to plasma collection reservoir 36. The concentrated formed element mixture from outlet port 26 flows through line 42 to junction 44, where replacement fluid from reservoir 46 is added. The makeup fluid from reservoir 46 is supplied to junction 44 by pump 48 at a controlled rate depending upon the particular patient and the setting of the control electronics for pump 48. For example, the makeup fluid could be pumped at a rate fasterthan plasma removal when it is desired to give the patient excess fluid to keep his blood pressure 30 high to avoid problems associated with low blood pressure. The makeup fluid could also, in some instances, be pumped at a rate slower than plasma removal. The concentrated formed element mixture and makeup fluid flowthrough line 47, drip chamber 43, and air bubble sensor 52 to return line 14, and from there to the patient.
During plasmapheresis, pump 16 is operated to cause blood flow at a desired rate, often the maximum rate achievable without deleterious effects to the particular patient or collapsing of the blood vessel that blood is being removed from. The shear rate can then be maintained at a desired level (i.e., high enough to avoid pore clogging but low enough to avoid hemolysis) by adjusting the height between membranes 112 and blood channels B by controlling the compression applied to separating device 20 by fixture 38.
The following equation describes shear rate, SR, for fully developed flow of a Newtonian fluid in a 40 rectangular channel where the width is sufficiently large in comparison to the height so that end effects can be neglected.
6Q Qb 113) (A p 2 45 SR =-r (1) m W f2 W ul where:
a = flowrate of fluid in the rectangular channel, 50 W = width of the channel, h = height of the channel, 1 = length of the channel, AP = pressure drop down the channel, and U = viscosity of the fluid. 55 It is seen from the first equivalence presented by Equation (1) thatthe shear rate is directly proportional to the flow of blood and inversely proportional to the square of height H of the channel. The second equivalence presented in Equation (1) shows that the pressure drop down the channel is related to, and is therefore a measure of, the shear rate and the channel height.
Figure 7 shows a channel B when the pressure from source 40 is low, and blood flow is relatively high.
Figure 8 shows the same channel when blood flow has decreased to a point that would require that blood channel height H be decreased to maintain the desired shear rate for the new conditions. This is done by increasing the pressure from source 40, which causes an increase in pressure between back plate 82 and piston plate 58 and the moving of plate 58 to the right (Figure 4), thereby compressing separating device 20 65 GB 2 151 943 A 5 between plate 58 and front plate 54. Some of the compression istaken up by membranes 112, and some of the compression istaken up by shims 114 and plastics plates 110. Because membranes 112 are already supported by tips 125, changes in thickness of the device 20 result in changing height H between membranes 112. This change in device thickness and thus channel height is controlled by apparatus 10 by monitoring 5 and controlling the pressure drop down blood channels B. In Figure 9, there is shown control electronics 160 for carrying out a particular protocol for operating apparatus 10. According to this protocol, height H is varied to result in a drop in pressure, AP, from blood inlet port 22 to blood outlet port 26 according to Equations (2) and (3):
AP = [1.0 m m Hg/ml/m in] X GB, for 40:QB:5 100 m Ilmin AP = 100 mm hg, for 160 GB: 100 ml/min (2) 10 (3) where:
GB is the total flow of blood into separating device 20.
The transmembrane pressure (TMP) near the outlet end of membranes 112 is maintained at 22 mm Hg, unless the plasma flow rate, Qp, increases to 0.6 of GB while trying to achieve a TMP of 25 mm Hg. In that case, Qp will be limited to 0.6 Of GB. The value of 25 mm Hg has been selected as the outlet TMP because it 20 results in a flux through membranes 112 that is acceptable at the same time that the transmembrane pressure near the inlet is kept at or below 125 mm Hg, which is not high enough to cause hemolysis or clogging of the pores. (The pressure in plasma channels P remains substantially constant along their lengths).
In carrying out the above-described protocol, A P control signal generator 162 receives signals from blood 25 pump 16 indicating total blood flow GB into device 20 and provides control signal A P', indicating the desired pressure drop through blood channels B to comparator 166 according to Equations (2) and (3). Subtracter 164 receives signals from blood pressure sensor 19 indicating the pressure of the blood at inlet 22 of device and signals from return pressure sensor 50 indicating the pressure of the concentrated formed element mixture leaving channels B at port 26 and provides a signal, A P, indicating the actual drop in pressure along 30 channels B to comparator 166. If A P' equals A P, comparator 166 provides signals to the motor of pressure source 40 to maintain the pressure in fixture 38 at its present level to maintain heights H in the blood channels B at the present value.
If A P' exceeds A P by more than a predetermined value, comparator 166 sends signals to the motor for source 40 to increase the pressure in fixture 38 to decrease heights H so that the actual pressure drop, A P, 35 will be increased to equal A P'. If A P'is less than A P, by more than a predetermined value, comparator 166 sends signals to the motor for source 40 to decrease the pressure in fixture 38 to result in increasing heights H in channels B. Pressure source 40 is monitored and controlled to prevent the pressure source 38 from exceeding safe pressure limits.
Subtracter 168 receives signals from return pressure sensor 50 indicating pressure in the concentrated 40 formed element mixture leaving channels B at port 26 and signals from plasma pressure sensor 37 indicating the pressure of the plasma in device 20 and provides an output signal, TIVIP, indicating the actual transmembrane pressure near the outlet end of separating device 20. Control 0 signal generator 172 (o is defined as Qp/QB) receives signals from blood pump 16 indicating the flow of blood into device 20, GB, and signals from plasma pump 34 indicating the flow of plasma, Qp, through the membranes and out of device 45 20, and provides control signal CS to TIVIP signal modifier 170. As Qp approaches 0.6 of QB, signal CS informs the TIVIP signal modifier 170, and TMP signal modifier 170 drives the plasma pump 34 so that Qp does not exceed 0.6 GB. If Qp does not approach 0.6 of GB, the TIVIP signal modifier drives the plasma pump 34 so that the desired TM P is achieved.
The formed element containing mixture need not be whole blood as in plasmapheresis as described 50 above; it could be red blood cells, white blood cells, and/or platelets which have been separated from whole blood and frozen in an electrolyte solution. Similarly, the invention is notlimited to separating formed elements, but also has application in separating bacteria or cultures of other cells (e.g., liver cells), which one wants to avoid destroying in the process of separating, and to separating precipitates or any other particles of sizes greater than the pore size from liquid mixtures of the particles.
In addition to varying the height of channels, the channel geometry can be actively varied by varying the width (from Equation (1) it is seen that shear rate varies with both height and width for a rectangular channel) orthe shape of the channels; e.g., one can compress the sides of a separating device to increase the channel height and decrease the channel width, or one can provide movable partitions to variably define the flow channels.
The geometry of the particle mixture channels (e.g., blood flow channels B) can be varied uniformly down the channels in response to other control protocols in addition to or in place of the maintenance of a proportional relationship between the pressure drop AP down the particle mixture channel and the flow of blood into the particle mixture channel described above. The other protocols can involve making control parameters of any of the following operating conditions: the pressure drop down the particle mixture 6 GB 2 151 943 A 6 channels, the pressure drop down the filtrate channels, the flow of the particle mixture, the particle concentration, the transmembrane pressure, and the flux.
Also, the geometry of the channels can be actively or passively varied along their lengths to optimize the separation as a function of location along the membranes. This is desirable because the flowrates and particle concentrations are different at different points along the membranes, and, associated with these different flowrates and particle concentrations, are optimal transmembrane pressures, velocity profiles (perpendicular to the membrane), and particle concentration profiles (perpendicular to the membrane) for achieving the desired filtration rate while avoiding plugging and particle destruction. One way of achieving this optimization is actively varying the particle mixture channel geometry along the entire channel in response to such operating conditions as the flowrate of the particle mixture, the concentration of particles, 10 the flux, the pressure drop in the particle mixture channel, the pressure drop in the filtrate channel, the transmembrane pressure profile along the membrane, the velocity profile in the particle mixture, and the concentration profile in the particle mixture. The operating conditions used become the control parameters forthe protocols. Another way to effect at least some of the desired results is to passively vary the geometry of the filtrate channel to cause a desired pressure gradient in the filtrate channel, as is described in detail below. Also, one can actively vary the geometry of the filtrate channel in response to the operating conditions. (One way of varying the filtrate channel geometry is providing Wgrooves by an accordian like member that can be expanded or contracted.) Changes in the filtrate channel geometry causes changes in the filtrate pressure, in turn affecting the TMP, in turn affecting the operating conditions in the particle mixture channel. Thus, the desired pressure gradient in the filtrate channel is the gradient which in conjunction with the pressure gradient in the particle mixture channel gives the preferred TMP and other operating conditions. These geometry changes in the particle mixture flow channel and the filtrate channel can be used together or independently.
By placing flow restriction means within the filtrate flow paths between the membranes and support plates, one can passively achieve pressure drops along the filtrate flow paths that approximate those along 25 the blood channel flow paths, thereby permitting the use of higher velocity gradients in the particle mixture flow channel, thus permitting a high flux along the entire length of the membrane. This flow resistance can be provided by making the Wgrooves shallower at the upstream end, where the flow is smaller, as is disclosed in Figure 10. Flow resistance can also be provided by replacing the V-grooves with surface roughness of high enough magnitude to permit flow but of low enough magnitude to provide the desired 30 pressure drop, or by placing flow obstructors, such as cloth or fibrous material, between the membranes and the membrane support plate. Also, the flow restriction can be such that, instead of providing a pressure drop approximating that in the blood channel flow path, one could provide a pressure drop to change the TMP along the membrane depending upon the concentration of formed elements or other operating conditions.
Also, the transmembrane pressure can be maintained by varying the flow of the particle mixture in addition to varying the filtrate pump, and can also be varied by varying the heights of the particle mixture channels. Other microporous membranes will work, and shims 114 can be avoided by providing for the desired blood channel depth by making tips 125 of V-grooves 122 lower in relation to surface 123.
Separating device 20 can contain any number of plasma-blood-plasma channel sets 108, or even just a plasma channel separated from a blood channel by a single membrane. If only a single plasma-blood plasma channel set 108 is desired, membrane support plates 110 are not required; membrane supporting V-grooves 122 can be provided on the interior surfaces of port plate 104 and end plate 106, which can be welded together as adjacent plates 110 are shown welded together in Figures 7 and 8.
In addition to compressing device 20 between front plate 54 and piston plate 58, device 20 could be secured to these plates, and a vacuum could be applied to depressions 84, 86 to expand device 20 to vary 45 heights H of blood channels B. The entire separating device need not be compressed, a bellows type device could be incorporated between port plate 104 and end plate 106 to compress the remainder of the housing means (i.e., shims 114, support plates 110 and membranes 112) to vary the heights of the particle mixture channels.
In place of the.004 inch thick polyethylene shim 114 one can use a thicker shim or one made of a more 50 elastic material, e.g., rubber, to provide a more compliant device to permit larger changes in the channel height H.

Claims (5)

1. A device for separating a liquid filtrate free of particles larger than a predetermined size from a liquid mixture of said particles, said device comprising a housing means including a port plate having a particle mixture inlet port, a particle mixture outlet port, and a filtrate outlet port, and an end plate, and a microporous membrane mounted between said plates to define a particle mixture flow channel and filtrate channel with said housing means, said particle mixture flow channel being in communication with said particle mixture inlet port and said particle mixture outlet port, said filtrate channel being in communication with said filtrate outlet port, the peripheries of said plates being welded together.
2. A device as claimed in claim 1 wherein said housing means includes a plurality of plastic membrane support plates between said port plate and said end plate, and there are a plurality of microporous membranes to define pluralities of particle mixture flow channels and filtrate channels with said housing 7 GB 2 151 943 A 7 means, the peripheries of said membrane support plates, said port plate, and said end plate being welded together.
3. A device as claimed in claim 1 or 2, wherein each said particle mixture flow channel is defined by two membranes.
4. A device as claimed in claim 1 or 2, wherein there is a shim providing a continuous seal around the periphery of at least one said membrane.
5. A device as claimed in claim 1 or 2, wherein said housing means includes means to provide a flow restriction in each said filtrate channel.
Printed in the UK for HMSO, D8818935, 6185, 7102. Published by The Patent Office, 25 Southampton Buildings, London, WC2A lAY, from which copies may be obtained.
GB08504768A 1981-10-01 1985-02-25 Plasmapheresis apparatus Expired GB2151943B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30748981A 1981-10-01 1981-10-01

Publications (3)

Publication Number Publication Date
GB8504768D0 GB8504768D0 (en) 1985-03-27
GB2151943A true GB2151943A (en) 1985-07-31
GB2151943B GB2151943B (en) 1986-01-02

Family

ID=23189998

Family Applications (4)

Application Number Title Priority Date Filing Date
GB08227714A Expired GB2112293B (en) 1981-10-01 1982-09-29 Plasmapheresis apparatus
GB08504767A Expired GB2151942B (en) 1981-10-01 1985-02-25 Plasmapheresis apparatus
GB08504768A Expired GB2151943B (en) 1981-10-01 1985-02-25 Plasmapheresis apparatus
GB08504766A Expired GB2151941B (en) 1981-10-01 1985-02-25 Holding and compressing device for plasmapheresis apparatus

Family Applications Before (2)

Application Number Title Priority Date Filing Date
GB08227714A Expired GB2112293B (en) 1981-10-01 1982-09-29 Plasmapheresis apparatus
GB08504767A Expired GB2151942B (en) 1981-10-01 1985-02-25 Plasmapheresis apparatus

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB08504766A Expired GB2151941B (en) 1981-10-01 1985-02-25 Holding and compressing device for plasmapheresis apparatus

Country Status (7)

Country Link
JP (1) JPS5870810A (en)
CA (1) CA1198686A (en)
DE (1) DE3236310A1 (en)
FR (1) FR2513896A1 (en)
GB (4) GB2112293B (en)
IT (1) IT1152566B (en)
NL (1) NL8202703A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9950321B2 (en) 2014-08-04 2018-04-24 General Electric Company Device for separation and collection of plasma
US10335078B2 (en) 2014-08-04 2019-07-02 General Electric Company Device for separation and collection of plasma

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980068A (en) * 1983-08-15 1990-12-25 Lavender Ardis R System, apparatus and method for continuously fractionating blood in situ
US4980054A (en) * 1983-08-15 1990-12-25 Lavender Ardis R System and method for mass transfer between fluids
JPS60183008A (en) * 1984-03-02 1985-09-18 Shokuhin Sangyo Maku Riyou Gijutsu Kenkyu Kumiai Membrane separation apparatus
JPS6145772A (en) * 1984-08-07 1986-03-05 テルモ株式会社 Serum separating method and apparatus
FR2581316A1 (en) * 1985-05-02 1986-11-07 Murisasco Antoine Method and device for automatic plasma exchanges controlled by an integrated computer
EP0208061A1 (en) * 1985-05-14 1987-01-14 Biotest Pharma GmbH Method and device for obtaining blood plasma
EP0341573A3 (en) * 1988-05-13 1990-05-09 Sartorius Ag Process and apparatus for the cross-flow filtration of liquids
FR2691911B1 (en) * 1992-06-05 1994-11-25 Delmas Olivier Device for obtaining a supernatant of activated thrombocytes, process using the device and obtained supernatant.
GB9224468D0 (en) * 1992-11-23 1993-01-13 Bio Flo Ltd Fluid treatment system
GB2305370B (en) * 1995-09-19 1997-10-29 Asahi Medical Co Device for depletion of leukocytes
ATE553835T1 (en) * 2001-09-20 2012-05-15 Emd Millipore Corp FILTER MODULE
ES2356811T3 (en) * 2001-09-20 2011-04-13 Millipore Corporation ELEMENT OF FLUID TRAVEL CONTROL FOR A FLUID TREATMENT MODULE.
EP2785429A4 (en) 2011-11-30 2015-10-28 Wellstat Diagnostics Llc Filtration module
US9081001B2 (en) 2012-05-15 2015-07-14 Wellstat Diagnostics, Llc Diagnostic systems and instruments
US9213043B2 (en) 2012-05-15 2015-12-15 Wellstat Diagnostics, Llc Clinical diagnostic system including instrument and cartridge
US9625465B2 (en) 2012-05-15 2017-04-18 Defined Diagnostics, Llc Clinical diagnostic systems
WO2016153428A1 (en) * 2015-03-23 2016-09-29 Nanyang Technological University Flow cell apparatus and method of analysing biofilm development

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK434874A (en) * 1974-08-14 1976-02-15 Danske Mejeriers Maskinfabrik FILTERING DEVICE
SE396017B (en) * 1974-12-23 1977-09-05 Alfa Laval Ab FILTRATION PROCEDURE, SPECIAL FOR ULTRA FILTRATION
US4191182A (en) * 1977-09-23 1980-03-04 Hemotherapy Inc. Method and apparatus for continuous plasmaphersis
US4212742A (en) * 1978-05-25 1980-07-15 United States Of America Filtration apparatus for separating blood cell-containing liquid suspensions
DE2823057A1 (en) * 1978-05-26 1979-11-29 Bayer Ag Semipermeable membrane unit - having set of spacers and membrane with appropriate holes which can be combined in modular form
IL58787A0 (en) * 1978-12-21 1980-02-29 Baxter Travenol Lab Disposable filter cell for membrane plasmapheresis
DE2925143C2 (en) * 1979-06-22 1983-11-17 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Device for continuous plasmapheresis
US4318813A (en) * 1980-06-30 1982-03-09 Baxter Travenol Laboratories, Inc. Membrane plasmapheresis module
JPS5935631B2 (en) * 1980-07-24 1984-08-29 テルモ株式会社 Body fluid “filtration” device
NZ198268A (en) * 1980-09-03 1984-03-30 Memtech Lab Pty Ltd Removal of micron and sub-micron particles from fluid
BR8207763A (en) * 1981-06-25 1983-07-19 Baxter Travenol Lab MEMBRANE PLASMAPHERESIS APPARATUS AND PROCESS USING A FLUID FLOW CONTROLLER DEVICE TO STABILIZE TRANSMEMBRANE PRESSURE

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9950321B2 (en) 2014-08-04 2018-04-24 General Electric Company Device for separation and collection of plasma
US10335078B2 (en) 2014-08-04 2019-07-02 General Electric Company Device for separation and collection of plasma

Also Published As

Publication number Publication date
GB2151943B (en) 1986-01-02
GB8504767D0 (en) 1985-03-27
GB8504768D0 (en) 1985-03-27
IT8223249A0 (en) 1982-09-14
IT1152566B (en) 1987-01-07
GB2151942B (en) 1986-01-02
DE3236310A1 (en) 1983-04-21
GB2112293B (en) 1986-01-02
GB8504766D0 (en) 1985-03-27
JPS5870810A (en) 1983-04-27
CA1198686A (en) 1985-12-31
GB2151941A (en) 1985-07-31
GB2151942A (en) 1985-07-31
GB2112293A (en) 1983-07-20
GB2151941B (en) 1986-01-02
FR2513896A1 (en) 1983-04-08
NL8202703A (en) 1983-05-02

Similar Documents

Publication Publication Date Title
GB2151943A (en) Plasmapheresis apparatus
US4798090A (en) Apparatus for use with fluid flow transfer device
US4666598A (en) Apparatus for use with fluid flow transfer device
US4770787A (en) Method of operating a fluid flow transfer device
US4735726A (en) Plasmapheresis by reciprocatory pulsatile filtration
US4493693A (en) Trans-membrane pressure monitoring system
US4906260A (en) Self-priming intravenous filter
EP0045073B1 (en) Body fluid filter device
JP3395911B2 (en) Cross-flow filter device with pressure balancing equipment
US4746436A (en) Membrane plasmapheresis apparatus and process which utilize a flexible wall to variably restrict the flow of plasma filtrate and thereby stabilize transmembrane pressure
US4636312A (en) Plasmapheresis filtration module having improved end plate
CA3201944A1 (en) Methods and systems for mechanoporation-based payload delivery into biological cells
EP0070738B1 (en) Plasmapheresis by reciprocatory pulsatile filtration
EP2445616B1 (en) Simulator device
CA1315706C (en) Transfer membrane apparatus
EP0082187B1 (en) Membrane plasmapheresis apparatus
JPH0365189B2 (en)
CN216909888U (en) Trace tangential flow plate type membrane test equipment
CA1252737A (en) Plasmapheresis filtration module
US4640776A (en) Plasmapheresis filtration module having pressure balancing and sealing means
CA1308569C (en) Pressure sensing apparatus
EP0089434A2 (en) Plasmapheresis filtration module
CA1269620A (en) Plasmapheresis by reciprocatory pulsatile filtration
Rodrigues Design of new membrane housings for a Portable Artificial Kidney
MXPA96001089A (en) System to obtain automatic plasma and method parapreparate fibrine gel from plasmaautol

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee